Technology area: Biotechnology & Pharmaceuticals
11 pending office actions • 9 art units • 11 examiners • 0 of 11 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Georgia State University Research Foundation Inc. has 11 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 11 distinct examiners and 9 distinct art units. Examiner distribution therefore matches the pending-action figure, while art-unit distribution is narrower and indicates some unit-level overlap.
HANEY, JONATHAN MICHAEL is the busiest examiner, with 1 pending matter. That figure shows no concentration around the named examiner, despite the portfolio's overall size. The prosecution workload is instead dispersed across the examiner group.
For counsel, the art-unit pattern may offer more useful coordination opportunities than examiner assignment. Actions can be tracked individually while related unit-level issues are reviewed for recurring technical or procedural themes.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (9%) |
| §103 only | 2 (18%) |
| Double-patenting only | 1 (9%) |
| Double-patenting + other | 3 (27%) |
| Multi-statute (no §101) | 4 (36%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HANEY, JONATHAN MICHAEL | 1 | 56.9% | +54.5% |
| MOSHER, ERIC PARKER | 1 | 100.0% | +0.0% |
| SAMALA, JAGADISHWAR RAO | 1 | 67.9% | +55.7% |
| MCCALL SHEPARD, SONYA D | 1 | 92.8% | +3.5% |
| VALENROD, YEVGENY | 1 | 72.5% | +25.1% |
| CHANDRAKUMAR, NIZAL S | 1 | 72.7% | +18.2% |
| DONOHUE, SEAN R | 1 | 41.4% | +21.0% |
| SWIFT, CANDICE LEE | 1 | 56.6% | +37.2% |
| CANDELARIA, JULIANA IRENE | 1 | 0.0% | +0.0% |
| DICKINSON, PAUL W | 1 | 63.2% | +9.6% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18834839 | RED-SHIFTED FLUOROPHORES AND METHODS OF USING THE SAME | MOSHER, ERIC PARKER | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17996573 | SIRPa Deficient Macrophages for Treating Cancer | CANDELARIA, JULIANA IRENE | 32d overdue |
| 18123236 | Small Molecule Ligand-Drug Conjugates for Targeted Cancer Therapy | DONOHUE, SEAN R | 2d overdue |
| 17610892 | SENSORS AND METHODS USING ELECTROCHEMILUMINESCENCE OF METAL NANOCLUSTERS | DICKINSON, PAUL W | 12d |
| 18870080 | System and Method for Mental Diagnosis Using EEG | HANEY, JONATHAN MICHAEL | — |
| 18730243 | PH-SENSITIVE FLUOROPHORES | SAMALA, JAGADISHWAR RAO | — |
| 18714464 | FLEXIBLE AND MINIATURIZED COMPACT VERTICAL COLOR SENSOR | MCCALL SHEPARD, SONYA D | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18123236 | Small Molecule Ligand-Drug Conjugates for Targeted Cancer Therapy | DONOHUE, SEAN R | 2d overdue |
| 18870080 | System and Method for Mental Diagnosis Using EEG | HANEY, JONATHAN MICHAEL | — |
| 18730243 | PH-SENSITIVE FLUOROPHORES | SAMALA, JAGADISHWAR RAO | — |
| 18682755 | BICYCLIC FUSED PYRAZOLE DERIVATIVES FOR THE TREATMENT OF RESPIRATORY INFECTIONS INCLUDING RSV | VALENROD, YEVGENY | — |
| 18577529 | THE USE OF BETA-HYDROXYBUTYRATES FOR THE TREATMENT OR PREVENTION OF ANEURYSMS AND DISSECTIONS | CHANDRAKUMAR, NIZAL S | — |
| 18012252 | PLASTIC POLYMER BIOCONVERSION PROCESS | SWIFT, CANDICE LEE | — |
| Art Unit | Apps |
|---|---|
| 1618 | 3 |
| 3791 | 1 |
| 1612 | 1 |
| 2898 | 1 |
| 1628 | 1 |
| 1625 | 1 |
| 1657 | 1 |
| 1634 | 1 |
| 1637 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18870080 | System and Method for Mental Diagnosis Using EEG | HANEY, JONATHAN MICHAEL | 3791 | §101§103 | Non-Final OA | — | Pending | Nov 27, 2024 |
| 18834839 | RED-SHIFTED FLUOROPHORES AND METHODS OF USING THE SAME | MOSHER, ERIC PARKER | 1612 | §102§103§112DP | Non-Final OA | — | Pending | Jul 31, 2024 |
| 18730243 | PH-SENSITIVE FLUOROPHORES | SAMALA, JAGADISHWAR RAO | 1618 | §102§103 | Non-Final OA | — | Pending | Jul 18, 2024 |
| 18714464 | FLEXIBLE AND MINIATURIZED COMPACT VERTICAL COLOR SENSOR | MCCALL SHEPARD, SONYA D | 2898 | §102§103 | Non-Final OA | — | Pending | May 29, 2024 |
| 18682755 | BICYCLIC FUSED PYRAZOLE DERIVATIVES FOR THE TREATMENT OF RESPIRATORY INFECTIONS INCLUDING RSV | VALENROD, YEVGENY | 1628 | §102§103§112DP | Non-Final OA | — | Pending | Feb 09, 2024 |
| 18577529 | THE USE OF BETA-HYDROXYBUTYRATES FOR THE TREATMENT OR PREVENTION OF ANEURYSMS AND DISSECTIONS | CHANDRAKUMAR, NIZAL S | 1625 | §103 | Non-Final OA | — | Pending | Jan 08, 2024 |
| 18123236 | Small Molecule Ligand-Drug Conjugates for Targeted Cancer Therapy | DONOHUE, SEAN R | 1618 | §103§112 | Non-Final OA | 2d overdue | Pending | Mar 17, 2023 |
| 18012252 | PLASTIC POLYMER BIOCONVERSION PROCESS | SWIFT, CANDICE LEE | 1657 | §103§112DP | Final Rejection | — | Pending | Dec 22, 2022 |
| 17996573 | SIRPa Deficient Macrophages for Treating Cancer | CANDELARIA, JULIANA IRENE | 1634 | DP | Final Rejection | 32d overdue | Pending | Oct 19, 2022 |
| 17610892 | SENSORS AND METHODS USING ELECTROCHEMILUMINESCENCE OF METAL NANOCLUSTERS | DICKINSON, PAUL W | 1618 | §103§112 | Final Rejection | 12d | Pending | Nov 12, 2021 |
| 17315987 | METHODS FOR GENERATING MACROPHAGES WITH ENHANCED CANCER PHAGOCYTOSIS | ANGELL, JON E | 1637 | §103 | Final Rejection | 17d overdue | Pending | May 10, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialGeorgia State University Research Foundation Inc. has 11 pending office actions as of October 2026, spread across 9 art units and 11 examiners.
Jonathan Michael Haney has the most, with 1 of Georgia State University Research Foundation Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
